Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
6.94
-0.30 (-4.14%)
At close: Jan 30, 2026, 4:00 PM EST
6.86
-0.08 (-1.22%)
After-hours: Jan 30, 2026, 7:52 PM EST
Alpha Tau Medical Market Cap
Alpha Tau Medical has a market cap or net worth of $591.73 million as of January 30, 2026. Its market cap has increased by 119.24% in one year.
Market Cap
591.73M
Enterprise Value
533.02M
1-Year Change
119.24%
Ranking
Category
Stock Price
$6.94
Market Cap Chart
Since March 8, 2021, Alpha Tau Medical's market cap has increased from $347.19M to $591.73M, an increase of 70.44%. That is a compound annual growth rate of 11.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 591.73M | 40.20% |
| Dec 31, 2025 | 422.06M | 94.21% |
| Dec 31, 2024 | 217.32M | 3.92% |
| Dec 29, 2023 | 209.12M | -4.71% |
| Dec 30, 2022 | 219.46M | -34.99% |
| Dec 31, 2021 | 337.56M | -2.77% |
| Mar 8, 2021 | 347.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evommune | 682.50M |
| SELLAS Life Sciences Group | 662.40M |
| ProKidney | 640.78M |
| Rigel Pharmaceuticals | 638.20M |
| CorMedix | 631.89M |
| MeiraGTx Holdings | 623.00M |
| Design Therapeutics | 602.11M |
| REGENXBIO | 587.23M |